Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06AUB
|
||||
Former ID |
DNC007930
|
||||
Drug Name |
1-benzyl-4-(2,4-dichlorophenyl)pyrrolidin-3-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H18Cl2N2
|
||||
Canonical SMILES |
C1C(C(CN1CC2=CC=CC=C2)N)C3=C(C=C(C=C3)Cl)Cl
|
||||
InChI |
1S/C17H18Cl2N2/c18-13-6-7-14(16(19)8-13)15-10-21(11-17(15)20)9-12-4-2-1-3-5-12/h1-8,15,17H,9-11,20H2
|
||||
InChIKey |
OHYGBKLWBNYXTE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [1] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2007 Apr 1;17(7):2005-12. Epub 2007 Jan 19.Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.